Safety and efficacy of radionuclide therapy with high-activity In-111 pentetreotide in patients with progressive neuroendocrine tumors.
about
Well-differentiated neuroendocrine tumors: a review covering basic principles to loco-regional and targeted therapiesSomatostatin receptor based imaging and radionuclide therapy.Radioembolization in the treatment of neuroendocrine tumor metastases to the liver.Long-Term Survival, Toxicity Profile, and role of F-18 FDG PET/CT scan in Patients with Progressive Neuroendocrine Tumors Following Peptide Receptor Radionuclide Therapy with High Activity In-111 Pentetreotide.Localized Irradiation of Cell Membrane by Auger Electrons Is Cytotoxic Through Oxidative Stress-Mediated Nontargeted Effects¹¹¹In-DTPA⁰-octreotide (Octreoscan), ¹³¹I-MIBG and other agents for radionuclide therapy of NETs.Triple targeting of Auger emitters using octreotate conjugated to a DNA-binding ligand and a nuclear localizing signal.Molecular Imaging Radiotherapy: Theranostics for Personalized Patient Management of Neuroendocrine Tumors (NETs).Production and dosimetric aspects of the potent Auger emitter 58mCo for targeted radionuclide therapy of small tumors.
P2860
Q33840177-A40F1970-5F0F-40FA-B8A0-B502B0E21AB7Q35296661-93346051-D6B3-49DE-97F6-65B857CF8403Q35659906-ACAEC6B4-8736-4DA9-A986-7217421C11BAQ35999552-21202E6F-6BC0-42E0-8182-00DFD72D7B4BQ37267538-F72B4038-70E3-4141-9A77-A9F9B82B0B9AQ37990403-52220E3D-1435-4398-BF35-D563EE117F0BQ38293084-E4D1F013-51AD-46F3-9EA5-62BBA4DBDCC4Q39590717-BFE02834-997B-489B-A3A0-B0A6F0A5BF94Q39706347-EB416B71-DF38-411E-8DBC-8DCA78D984E9
P2860
Safety and efficacy of radionuclide therapy with high-activity In-111 pentetreotide in patients with progressive neuroendocrine tumors.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Safety and efficacy of radionu ...... ressive neuroendocrine tumors.
@ast
Safety and efficacy of radionu ...... ressive neuroendocrine tumors.
@en
type
label
Safety and efficacy of radionu ...... ressive neuroendocrine tumors.
@ast
Safety and efficacy of radionu ...... ressive neuroendocrine tumors.
@en
prefLabel
Safety and efficacy of radionu ...... ressive neuroendocrine tumors.
@ast
Safety and efficacy of radionu ...... ressive neuroendocrine tumors.
@en
P2093
P356
P1476
Safety and efficacy of radionu ...... ressive neuroendocrine tumors.
@en
P2093
Ali Azhdarinia
Ebrahim S Delpassand
Eugene Woltering
Faramarz Ashoori
Farzad Torabi
Gregory Espenan
Hitomi Saso
Jennifer Sims-Mourtada
Lowell Anthony
Warren H Moore
P304
P356
10.1089/CBR.2007.0448
P577
2008-06-01T00:00:00Z